Isolated Splenic Metastasis of Primary Lung Cancer Presented as Metachronous Oligometastatic Disease-A Case Report

Modern oncology practice and new antitumor drugs prolonged disease-free intervals in patients with lung cancer. Patients with distant metastatic disease are treated only with palliative intent. The International Association for the Study of Lung Cancer, in the 8th edition of the TNM classification,...

Full description

Saved in:
Bibliographic Details
Published in:Diagnostics (Basel) 2022-01, Vol.12 (1), p.209
Main Authors: Reljic, Milorad, Tadic, Boris, Stosic, Katarina, Mitrovic, Milica, Grubor, Nikola, Kmezic, Stefan, Ceranic, Miljan, Milosavljevic, Vladimir
Format: Article
Language:English
Subjects:
Abdomen
Asymptomatic
Biopsy
Cancer therapies
Case Report
Case reports
Chemotherapy
Conflicts of interest
Councils
Disease
isolated splenic metastasis
Laparoscopy
Lung cancer
Magnetic resonance imaging
Metastasis
oligometastatic disease
Oncology
Patients
Spleen
Surgery
Surveillance
Tomography
Ultrasonic imaging
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Modern oncology practice and new antitumor drugs prolonged disease-free intervals in patients with lung cancer. Patients with distant metastatic disease are treated only with palliative intent. The International Association for the Study of Lung Cancer, in the 8th edition of the TNM classification, for the first time includes oligometastatic disease as a clinical state that describes the patients with distant metastasis, limited in number and organ sites, who may have more indolent biology. In this paper, we present a case of a 56-year-old man who was admitted to our clinic regarding a radiologically diagnosed splenic lesion of uncertain nature, and who underwent a left upper lobectomy for primary lung cancer 12 years before. After a detailed radiological diagnosis, it was concluded that it is highly suspected metastatic lesion of the spleen and the patient underwent a splenectomy. While no definitive protocols exist on the management of isolated splenic metastasis from lung cancer, splenectomy, in suitable patients, with reasonable survival expectations, improves patient disease-free survival and can prevent potentially life-threatening complications, such as splenic rupture. F-FDG PET has very high sensitivity and specificity for differentiating benign and malignant splenic lesions especially in patients who are in the follow up protocol due to primary malignancy.
ISSN:2075-4418
2075-4418
DOI:10.3390/diagnostics12010209